Healthcare -
Biotechnology - NASDAQ - US
$ 1.27
0 %
$ 37.9 M
Market Cap
-0.64
P/E
ANTX - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities ANTX - AN2 Therapeutics, Inc.
-43.3 M
LAST VALUE
6.99%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR